Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has been notified by Slater Investments of a significant change in their holding, with an increase in voting rights to 13.08% as of July 22, 2024. This noteworthy change, which crosses a threshold, reflects a substantial acquisition of additional shares, resulting in a total of over 70 million voting rights within the company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
